| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0021 | 1 |